CVS Health Corporation

106.39+2.14+2.05%Vol 5.01M1Y Perf 22.45%
Aug 12th, 2022 16:00 DELAYED
BID106.25 ASK106.68
Open105.00 Previous Close104.25
Pre-Market- After-Market106.44
 - -  0.05 0.05%
Target Price
116.80 
Analyst Rating
Moderate Buy 1.63
Potential %
9.78 
Finscreener Ranking
     41.16
Insiders Trans % 3/6/12 mo.
-100/-89/-79 
Value Ranking
     41.63
Insiders Value % 3/6/12 mo.
-100/-99/-98 
Growth Ranking
★+     42.69
Insiders Shares Cnt. % 3/6/12 mo.
-100/-99/-98 
Income Ranking
     31.71
Price Range Ratio 52W %
83.51 
Earnings Rating
Neutral
Market Cap139.67B 
Earnings Date
3rd Aug 2022
Alpha0.00 Standard Deviation0.08
Beta0.77 

Today's Price Range

104.88106.87

52W Range

81.78111.25

5 Year PE Ratio Range

-89.2019.20

Summary:

Buy

Technical Indicators: Neutral
Moving Averages: Strong Buy
Performance
1 Week
4.04%
1 Month
13.85%
3 Months
9.14%
6 Months
2.06%
1 Year
22.45%
3 Years
77.76%
5 Years
33.98%
10 Years
149.61%

TickerPriceChg.Chg.%
CVS106.392.14002.05
AAPL172.123.63002.15
GOOG122.652.83002.36
MSFT291.914.89001.70
XOM94.000.81000.87
WFC45.940.69001.52
JNJ165.30-1.8400-1.10
FB196.640.99000.51
GE79.931.03001.31
JPM122.131.99001.66
 
ProfitabilityValueIndustryS&P 500US Markets
17.40
4.20
5.70
2.90
2.68
RevenueValueIndustryS&P 500US Markets
307.86B
234.50
9.47
11.35
DividendsValueIndustryS&P 500US Markets
2.11
2.20
0.24
1.44
Payout ratio35.00
Earnings HistoryEstimateReportedSurprise %
Q02 20222.162.4011.11
Q01 20222.142.223.74
Q04 20211.941.982.06
Q03 20211.791.9710.06
Q02 20212.072.4216.91
Q01 20211.722.0418.60
Q04 20201.241.304.84
Q03 20201.341.6623.88
Earnings Per EndEstimateRevision %Trend
6/2022 QR2.16-0.92Negative
9/2022 QR2.060.98Positive
12/2022 FY8.341.34Positive
12/2023 FY9.183.03Positive
Next Report Date-
Estimated EPS Next Report2.16
Estimates Count10
EPS Growth Next 5 Years %7.60
Volume Overview
Volume5.01M
Shares Outstanding1.31M
Shares Float1.31B
Trades Count63.28K
Dollar Volume531.62M
Avg. Volume4.66M
Avg. Weekly Volume4.22M
Avg. Monthly Volume4.97M
Avg. Quarterly Volume4.79M

CVS Health Corporation (NYSE: CVS) stock closed at 106.39 per share at the end of the most recent trading day (a 2.05% change compared to the prior day closing price) with a volume of 5.01M shares and market capitalization of 139.67B. Is a component of S&P 500, Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Healthcare Plans industry, Healthcare sector and employs 300000 people. CVS Health Corporation CEO is Karen S. Lynch.

The one-year performance of CVS Health Corporation stock is 22.45%, while year-to-date (YTD) performance is 3.13%. CVS stock has a five-year performance of 33.98%. Its 52-week range is between 81.78 and 111.25, which gives CVS stock a 52-week price range ratio of 83.51%

CVS Health Corporation currently has a PE ratio of 17.00, a price-to-book (PB) ratio of 1.82, a price-to-sale (PS) ratio of 0.44, a price to cashflow ratio of 7.50, a PEG ratio of 2.32, a ROA of 3.76%, a ROC of 6.61% and a ROE of 11.67%. The company’s profit margin is 2.68%, its EBITDA margin is 5.70%, and its revenue ttm is $307.86 Billion , which makes it $234.50 revenue per share.

Of the last four earnings reports from CVS Health Corporation, there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $2.16 for the next earnings report. CVS Health Corporation’s next earnings report date is -.

The consensus rating of Wall Street analysts for CVS Health Corporation is Moderate Buy (1.63), with a target price of $116.8, which is +9.78% compared to the current price. The earnings rating for CVS Health Corporation stock is Neutral (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

CVS Health Corporation has a dividend yield of 2.11% with a dividend per share of $2.20 and a payout ratio of 35.00%.

CVS Health Corporation has a Buy technical analysis rating based on Technical Indicators (ADX : 8.65, ATR14 : 2.14, CCI20 : 131.98, Chaikin Money Flow : 0.11, MACD : 2.83, Money Flow Index : 82.31, ROC : 10.97, RSI : 80.29, STOCH (14,3) : 96.22, STOCH RSI : 1.00, UO : 52.14, Williams %R : -3.78), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of CVS Health Corporation in the last 12-months were: Alan M. Lotvin (Option Excercise at a value of $10 432 875), Alan M. Lotvin (Sold 164 826 shares of value $16 469 932 ), Daniel P. Finke (Option Excercise at a value of $2 960 553), Daniel P. Finke (Sold 70 846 shares of value $7 091 795 ), Edward J. Ludwig (Buy at a value of $105 904), James D. Clark (Option Excercise at a value of $619 593), James D. Clark (Sold 6 059 shares of value $660 431 ), Jonathan C. Roberts (Option Excercise at a value of $12 003 368), Jonathan C. Roberts (Sold 177 352 shares of value $17 704 465 ), Prem S. Shah (Option Excercise at a value of $1 716 473), Prem S. Shah (Sold 26 924 shares of value $2 833 046 ), Thomas M. Moriarty (Option Excercise at a value of $13 752 572), Thomas M. Moriarty (Sold 190 015 shares of value $18 565 035 ), Troyen A. Brennan (Option Excercise at a value of $10 923 493), Troyen A. Brennan (Sold 161 478 shares of value $15 318 371 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
8 (53.33 %)
7 (50.00 %)
7 (50.00 %)
Moderate Buy
4 (26.67 %)
4 (28.57 %)
4 (28.57 %)
Hold
3 (20.00 %)
3 (21.43 %)
3 (21.43 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingModerate Buy
1.63
Moderate Buy
1.68
Moderate Buy
1.68

CVS Health Corporation

Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with over 23 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.

CEO: Karen S. Lynch

Telephone: +1 401 765-1500

Address: One CVS Drive, Woonsocket 02895, RI, US

Number of employees: 300 000

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

67%33%

Bearish Bullish

59%41%

Bearish Bullish

58%42%

Bearish Bullish

58%42%

TipRanks News for CVS

Fri, 05 Aug 2022 12:45 GMT CVS Health (CVS) Receives a Buy from Jefferies

- TipRanks. All rights reserved.

Mon, 04 Jul 2022 22:17 GMT CVS Health Stock: A Recession-Proof Cash Cow

- TipRanks. All rights reserved.

Tue, 21 Jun 2022 12:45 GMT Analysts Have Conflicting Sentiments on These Consumer Goods Companies: Arhaus (ARHS), CVS Health (CVS) and Natura & Co Holding (NTCO)

- TipRanks. All rights reserved.

Tue, 21 Jun 2022 12:36 GMT Analysts Have Conflicting Sentiments on These Consumer Goods Companies: CVS Health (CVS) and BellRing Brands (BRBR)

- TipRanks. All rights reserved.

Fri, 06 May 2022 03:55 GMT CVS Health (CVS) Receives a Buy from Mizuho Securities

- TipRanks. All rights reserved.

Fri, 06 May 2022 03:50 GMT CVS Health (CVS) Receives a Buy from Evercore ISI

- TipRanks. All rights reserved.

Fri, 06 May 2022 01:51 GMT CVS Health (CVS) Gets a Buy Rating from RBC Capital

- TipRanks. All rights reserved.

Tue, 03 May 2022 09:13 GMT CVS Health Reports Earnings Tomorrow What Can We Expect

- TipRanks. All rights reserved.

Mon, 25 Apr 2022 13:15 GMT CVS Health (CVS) Gets a Hold Rating from Deutsche Bank

- TipRanks. All rights reserved.

Wed, 13 Apr 2022 09:40 GMT CVS Health (CVS) Gets a Buy Rating from Mizuho Securities

- TipRanks. All rights reserved.

Mon, 11 Apr 2022 17:34 GMT CVS Health: A Healthy Stock with Some Risks

- TipRanks. All rights reserved.

Thu, 07 Apr 2022 16:36 GMT CVS Health (CVS) Receives a Buy from Tigress Financial

- TipRanks. All rights reserved.

Fri, 18 Mar 2022 12:15 GMT Evercore ISI Believes CVS Health (CVS) Still Has Room to Grow

- TipRanks. All rights reserved.

Tue, 15 Feb 2022 18:02 GMT CVS Stock: Outlook Remains Positive

- TipRanks. All rights reserved.

Fri, 11 Feb 2022 12:14 GMT J.P. Morgan Believes CVS Health (CVS) Still Has Room to Grow

- TipRanks. All rights reserved.

Fri, 11 Feb 2022 10:03 GMT CVS Health Updates 2 Key Risk Factors

- TipRanks. All rights reserved.

Sun, 23 Jan 2022 16:49 GMT Jefferies Believes CVS Health (CVS) Still Has Room to Grow

- TipRanks. All rights reserved.

Sat, 22 Jan 2022 09:03 GMT Analysts Top Consumer Goods Picks: CVS Health (CVS)

- TipRanks. All rights reserved.

Wed, 19 Jan 2022 12:36 GMT Mizuho Securities Believes CVS Health (CVS) Wont Stop Here

- TipRanks. All rights reserved.

Mon, 17 Jan 2022 15:11 GMT CVS Stock: Could Outperform in 2022

- TipRanks. All rights reserved.

Mon, 17 Jan 2022 06:08 GMT RBC Capital Believes CVS Health (CVS) Wont Stop Here

- TipRanks. All rights reserved.

Sun, 16 Jan 2022 12:02 GMT CVS Health Corp.: Healthy Growth, but Worth the Price

- TipRanks. All rights reserved.

News

Stocktwits